Ad-hoc | 8 November 2017 10:04
|
SINGULUS TECHNOLOGIES AG / Key word(s): Incoming Orders/Market launch
Disclosure of inside information pursuant to Article 17 of MAR
The systems are to be supplied to a global active company in the medical sector. This entry into the high-growth market of medical technology represents a strategically important broadening of the portfolio with an eye to the future. SINGULUS TECHNOLOGIES has been working together with this key customer on a development project for some time now, and has developed a new processing system for the production of contact lenses. The new processing system cleans residual material from contact lenses and then coats the lenses in a further process step.
Contact:
08-Nov-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|
| Language: | English |
| Company: | SINGULUS TECHNOLOGIES AG |
| Hanauer Landstrasse 103 | |
| 63796 Kahl am Main | |
| Germany | |
| Phone: | +49 (0)1709202924 |
| Fax: | +49 (0)6188 440-110 |
| E-mail: | bernhard.krause@singulus.de |
| Internet: | www.singulus.de |
| ISIN: | DE000A1681X5, DE000A2AA5H5 |
| WKN: | A1681X, A2AA5H |
| Listed: | Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| End of Announcement | DGAP News Service |